BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28392550)

  • 1. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
    Hwang SM; Lee KC; Lee MS; Park KU
    Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
    Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
    PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
    Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
    Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model.
    Tarabeux J; Zeitouni B; Moncoutier V; Tenreiro H; Abidallah K; Lair S; Legoix-Né P; Leroy Q; Rouleau E; Golmard L; Barillot E; Stern MH; Rio-Frio T; Stoppa-Lyonnet D; Houdayer C
    Eur J Hum Genet; 2014 Apr; 22(4):535-41. PubMed ID: 23942203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
    Shin S; Hwang IS; Lee ST; Choi JR
    Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
    Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
    J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of false positive mutations in BRCA gene by next generation sequencing.
    Suryavanshi M; Kumar D; Panigrahi MK; Chowdhary M; Mehta A
    Fam Cancer; 2017 Jul; 16(3):311-317. PubMed ID: 27848044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of BRCA1 and BRCA2 genes by next generation sequencing and ultrastructural aspects of breast tumor tissue.
    Mihalcea CE; Moroşanu AM; Murăraşu D; Puiu L; Cinca SA; Voinea SC; Mirancea N
    Rom J Morphol Embryol; 2017; 58(2):445-455. PubMed ID: 28730229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
    Pilato B; Pinto R; De Summa S; Petriella D; Lacalamita R; Danza K; Paradiso A; Tommasi S
    Genes Chromosomes Cancer; 2016 Oct; 55(10):803-13. PubMed ID: 27225819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
    D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
    Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of
    Lee EJ; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Kim HS; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    Ann Clin Lab Sci; 2020 Jan; 50(1):107-118. PubMed ID: 32161019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection.
    Capone GL; Putignano AL; Trujillo Saavedra S; Paganini I; Sestini R; Gensini F; De Rienzo I; Papi L; Porfirio B
    J Mol Diagn; 2018 Jan; 20(1):87-94. PubMed ID: 29061375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
    Park K; Kim MK; Lee T; Hong J; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    J Clin Lab Anal; 2020 Dec; 34(12):e23524. PubMed ID: 32812259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing of
    Nicolussi A; Belardinilli F; Mahdavian Y; Colicchia V; D'Inzeo S; Petroni M; Zani M; Ferraro S; Valentini V; Ottini L; Giannini G; Capalbo C; Coppa A
    PeerJ; 2019; 7():e6661. PubMed ID: 31065452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for genetic mutations in hyperphenylalaninemia using Ion Torrent PGM sequencing].
    Cao Y; Qu Y; Song F; Bai J; Jin Y; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):16-20. PubMed ID: 25636092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
    Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.